Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole versus misoprostol for post-abortion retained products of conception
IRCT20210529051424N3Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Jun 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in retained placenta comparing Letrozole with Misoprostol (2 arms). Primary endpoints: Complete evacuation of the products of pregnancy, Amount and type of bleeding and 1 more. Started Jun 2025; status: completed.
02
Drugs
letrozolemisoprostol
03
Conditions
retained placenta
Beyond the preview
Go deeper on IRCT20210529051424N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210529051424N3.